An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, TYPE C; found in platelets, brain, and other tissues.
Diphosphoric acid esters of fructose. The fructose-1,6- diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process.
Allosteric enzymes that regulate glycolysis and gluconeogenesis. These enzymes catalyze phosphorylation of fructose-6-phosphate to either fructose-1,6-bisphosphate (PHOSPHOFRUCTOKINASE-1 reaction), or to fructose-2,6-bisphosphate (PHOSPHOFRUCTOKINASE-2 reaction).
Contractile tissue that produces movement in animals.
An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.

Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. (1/109)

The purpose of this study was to analyse key enzyme activities of the deltoid muscle (DM) in chronic obstructive pulmonary disease (COPD) patients. The activities of one oxidative enzyme (citrate synthase (CS)), two glycolytic enzymes (lacatate dehydrogenase (LD); and phosphofructokinase (PFK)) and one enzyme related to the use of energy stores (creatine kinase (CK)) were determined in the DM of 10 patients with COPD and nine controls. Exercise capacity (cycloergometry) and the handgrip strength were also evaluated. Although exercise capacity was markedly reduced in COPD (57 +/- 20% predicted), their handgrip strength was relatively preserved (77 +/- 19% pred). The activity of LD was higher in the COPD patients (263.9 +/- 68.2 versus 184.4 +/- 46.5 mmol x min(-1) x g(-1), p<0.01), with a similar trend for CS (67.3 +/- 33.3 versus 46.0 +/- 17.4 mmol x min(-1) x g(-1), p = 0.07). Interestingly, the activity of the latter enzyme was significantly higher than controls if only severe COPD patients were considered (81.8 +/- 31.2 mmol x min(-1) x g(-1), p < 0.01). PFK and CK activities were similar for controls and COPD. Chronic obstructive patients show a preserved or even increased (severe disease) oxidative capacity in their deltoid muscle. This coexists with a greater capacity in the anaerobic part of the glycolysis. These findings are different to those previously observed in muscles of the lower limbs.  (+info)

Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy. (2/109)

1. In ischaemic exercise ATP is supplied only by glycogenolysis and net splitting of phosphocreatine (PCr). Furthermore, 'proton balance' involves only glycolytic lactate/H+ generation and net H+ 'consumption' by PCr splitting. This work examines the interplay between these, metabolic regulation and the creatine kinase equilibrium. 2. Nine male subjects (age 25-45 years) performed finger flexion (7 % maximal voluntary contraction at 0.67 Hz) under cuff ischaemia. 31P magnetic resonance spectra were acquired from finger flexor muscle in a 4.7 T magnet using a 5 cm surface coil. 3. Initial PCr depletion rate estimates total ATP turnover rate; glycolytic ATP synthesis was obtained from this and changes in [PCr], and then used to obtain flux through 'distal' glycolysis (phosphofructokinase and beyond) to lactate; 'proximal' flux (through phosphorylase) was obtained from this and changes in [phosphomonoester]. Total H+ load (lactate load less H+ consumption) was used to estimate cytosolic buffer capacity (beta). 4. Glycolytic ATP synthesis increased from near zero while PCr splitting declined. Net H+ load was approximately linear with pH, suggesting beta = 20 mmol x l(-1) (pH unit)(-1) at rest, increasing as pH falls. 5. Relationships between glycolytic rate and changes in [PCr] (i.e. the time-integrated mismatch between ATP use and production), and thus also [P(i)] (substrate for phosphorylase), suggest that increase in glycolysis is due partly to 'open-loop' Ca2+-dependent conversion of phosphorylase b to a, and partly to the 'closed loop' increase in P(i) consequent on net PCr splitting. 6. The 'settings' of these mechanisms have a strong influence on changes in pH and metabolite concentrations.  (+info)

Creation of an allosteric phosphofructokinase starting with a nonallosteric enzyme. The case of dictyostelium discoideum phosphofructokinase. (3/109)

An allosteric phosphofructokinase (PFK) was created by sequence manipulation of the nonallosteric enzyme from the slime mold Dictyostelium discoideum (DdPFK). Most amino acid residues proposed as important for catalytic and allosteric sites are conserved in DdPFK except for a few of them, and their reversion did not modify its kinetic behavior. However, deletions at the unique C-terminal extension of this PFK produced a markedly allosteric enzyme. Thus, a mutant lacking the last 26 C-terminal residues exhibited hysteresis in the time course, intense cooperativity (n(H) = 3.8), and a 200-fold decrease in the apparent affinity for fructose 6-phosphate (S(0.5) = 4500 microm), strong activation by fructose 2,6-bisphosphate (K(act) = 0.1 microm) and fructose 1,6-bisphosphate (K(act) = 40 microm), dependence on enzyme concentration, proton inhibition, and subunit association-dissociation in response to fructose 6-phosphate versus the nonhysteretic and hyperbolic wild-type enzyme (n(H) = 1.0; K(m) = 22 microm) that remained as a stable tetramer. Systematic deletions and point mutations at the C-tail region of DdPFK identified the last C-terminal residue, Leu(834), as critical to produce a nonallosteric enzyme. All allosteric mutants were practically insensitive to MgATP inhibition, suggesting that this effect does not involve the same allosteric transition as that responsible for fructose 6-phosphate cooperativity and fructose bisphosphate activation.  (+info)

Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity. (4/109)

In this study, we examined whether weight loss-induced changes in plasma organochlorine compounds (OC) were associated with those in skeletal muscle markers of glycolytic and oxidative metabolism. Vastus lateralis skeletal muscle enzyme activities and plasma OC (Aroclor 1260, polychlorinated biphenyl 153, p,p'-DDE, beta-hexachlorocyclohexane, and hexachlorobenzene) were measured before and after a weight loss program in 17 men and 20 women. Both sexes showed a similar reduction in body weight (approximately 11 kg) in response to treatment, although men lost significantly more fat mass than women (P < 0.05). Enzymatic markers of glycolysis, phosphofructokinase (PFK) activity, and oxidative metabolism, beta-hydroxyacyl-CoA dehydrogenase (HADH), citrate synthase (CS), and cytochrome c oxidase (COX) activities, remained unchanged after weight loss. A significant increase in plasma OC levels was observed in response to weight loss, an effect that was more pronounced in men. No relationship was observed between changes in OC and those in PFK activity in either sex [-0.31 < r < 0.12, not significant (NS)]. However, the greater the increase in plasma OC levels, the greater the reduction in oxidative enzyme (HADH, CS, COX) activities was in response to weight loss in men (-0.75 < r < -0.50, P < 0.05) but not in women (-0.33 < r < 0.33, NS). These results suggest that the weight loss-induced increase in plasma pollutant levels is likely to be associated with reduced skeletal muscle oxidative metabolism in men but not in women.  (+info)

Mitochondrial biogenesis during skeletal muscle regeneration. (5/109)

Myogenesis requires energy production for the execution of a number of regulatory and biosynthesis events. We hypothesized that mitochondrial biogenesis would be stimulated during skeletal muscle regeneration. Tibialis anterior muscles of male Sprague-Dawley rats were injected with 0.75% bupivacaine and removed at 3, 5, 7, 10, 14, 21, or 35 days after injection (n = 5-7/group). Two main periods emerged from the histochemical analyses of muscle sections and the expression of proliferating cell nuclear antigen, desmin, and creatine phosphokinase: 1) activation/proliferation of satellite cells (days 3-14) and 2) differentiation into muscle fibers (days 5-35). The onset of muscle differentiation was accompanied by a marked stimulation of mitochondrial biogenesis, as indicated by a nearly fivefold increase in citrate synthase activity and state 3 rate of respiration between days 5 and 10. Peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) mRNA level and mitochondrial transcription factor A (mtTFA) protein level peaked on day 10 concurrently with the state 3 rate of respiration. Therefore, transcriptional activation by PGC-1 and mtTFA may be one of the mechanisms regulating mitochondrial biogenesis in regenerating skeletal muscle. Taken together, our results suggest that mitochondrial biogenesis may be an important regulatory event during muscle regeneration.  (+info)

Differing mechanisms of cold-induced changes in capillary supply in m. tibialis anterior of rats and hamsters. (6/109)

The physiological, metabolic and anatomical adaptations of skeletal muscle to chronic cold exposure were investigated in Wistar rats (Rattus norvegicus), a species that defends core temperature, and Syrian hamsters (Mesocricetus auratus), which may adopt a lower set point under unfavourable conditions. Animals were exposed to a simulated onset of winter in an environmental chamber, progressively shortening photoperiod and reducing temperature from 12 h:12 h L:D and 22 degrees C to 1 h:23 h L:D and 5 degrees C over 4 weeks. The animals were left at 4 degrees C for a further 4 weeks to complete the process of cold-acclimation. M. tibialis anterior from control (euthermic) and cold-acclimated animals of similar mass showed a significant hyperactivity-induced hypertrophy in the rat, but a small disuse atrophy in the hamster. Little evidence was found for interconversion among fibre types in skeletal muscle on cold-acclimation, and only modest differences were seen in activity of oxidative or glycolytic enzymes in either species. However, adjustments in Type II fibre size paralleled the muscle hypertrophy in rat and atrophy in hamster. Cold-induced angiogenesis was present in the rat, averaging a 28 % increase in capillary-to-fibre ratio (C:F) but, as this was balanced by fibre hypertrophy across the whole muscle, there was no change in capillary density (CD). In contrast, the C:F was similar in both groups of hamsters, whereas CD rose by 33 % in line with fibre atrophy. Within distinct regions of the m. tibialis anterior, there was a correlation between angiogenesis and fibre size in rats, in which oxygen diffusion distance increased, but not in hamsters, in which there was a reduced oxygen diffusion distance. Consequently, the change in C:F was greatest (39 %) in the glycolytic cortex region of the m. tibialis anterior in rats. We conclude that non-hibernator and hibernator rodents improve peripheral oxygen transport following cold-acclimation by different mechanisms. In rats, an increase in fibre girth was accompanied by a true angiogenesis, while the improved apparent capillary supply in hamsters was due to smaller fibre diameters. These responses are consistent with the strategies of resisting and accommodating, respectively, an annual fall in environmental temperature.  (+info)

Modulation of gene expression made easy. (7/109)

A new approach for modulating gene expression, based on randomization of promoter (spacer) sequences, was developed. The method was applied to chromosomal genes in Lactococcus lactis and shown to generate libraries of clones with broad ranges of expression levels of target genes. In one example, overexpression was achieved by introducing an additional gene copy into a phage attachment site on the chromosome. This resulted in a series of strains with phosphofructokinase activities from 1.4 to 11 times the wild-type activity level. In this example, the pfk gene was cloned upstream of a gusA gene encoding beta-glucuronidase, resulting in an operon structure in which both genes are transcribed from a common promoter. We show that there is a linear correlation between the expressions of the two genes, which facilitates screening for mutants with suitable enzyme activities. In a second example, we show that the method can be applied to modulating the expression of native genes on the chromosome. We constructed a series of strains in which the expression of the las operon, containing the genes pfk, pyk, and ldh, was modulated by integrating a truncated copy of the pfk gene. Importantly, the modulation affected the activities of all three enzymes to the same extent, and enzyme activities ranging from 0.5 to 3.5 times the wild-type level were obtained.  (+info)

The structure of a pyrophosphate-dependent phosphofructokinase from the Lyme disease spirochete Borrelia burgdorferi. (8/109)

The structure of the 60 kDa pyrophosphate (PP(i))-dependent phosphofructokinase (PFK) from Borrelia burgdorferi has been solved and refined (R(free) = 0.243) at 2.55 A resolution. The domain structure of eubacterial ATP-dependent PFKs is conserved in B. burgdorferi PFK, and there are three large insertions relative to E. coli PFK, including a helical domain containing a hairpin structure that interacts with the active site. Asp177, conserved in all PP(i) PFKs, negates the binding of the alpha-phosphate group of ATP and likely contacts the essential Mg(2+) cation via a water molecule. Asn181 blocks the binding of the adenine moiety of ATP. Lys203 hydrogen bonds to a sulfate anion that likely mimics PP(i) substrate binding.  (+info)

Phosphofructokinase-1 (PFK-1) is a rate-limiting enzyme in the glycolytic pathway, which is the metabolic pathway that converts glucose into pyruvate, producing ATP and NADH as energy currency for the cell. PFK-1 plays a crucial role in regulating the rate of glycolysis by catalyzing the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, using ATP as the phosphate donor.

PFK-1 is allosterically regulated by various metabolites, such as AMP, ADP, and ATP, which act as positive or negative effectors of the enzyme's activity. For example, an increase in the intracellular concentration of AMP or ADP can activate PFK-1, promoting glycolysis and energy production, while an increase in ATP levels can inhibit the enzyme's activity, conserving glucose for use under conditions of low energy demand.

Deficiencies in PFK-1 can lead to a rare genetic disorder called Tarui's disease or glycogen storage disease type VII, which is characterized by exercise intolerance, muscle cramps, and myoglobinuria (the presence of myoglobin in the urine due to muscle damage).

I'm sorry for any confusion, but "Fructosediphosphates" is not a recognized term in medicine or biochemistry. It's possible there may be a spelling mistake or misunderstanding in the term you're looking for.

If you meant "Fructose 1,6-bisphosphate," that is a key intermediate in carbohydrate metabolism. It's formed from fructose 6-phosphate in the process of glucose breakdown (glycolysis) and is then used in the generation of energy through the citric acid cycle.

If these terms are not what you were looking for, could you please provide more context or check the spelling? I'm here to help!

Phosphofructokinase (PFK) is an enzyme that plays a crucial role in regulating glycolysis, which is the metabolic pathway responsible for the conversion of glucose into energy. PFK catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, using a molecule of adenosine triphosphate (ATP) as a source of energy. This reaction is a key regulatory step in glycolysis and is subject to allosteric regulation by various metabolites, such as ATP, ADP, and citrate, that signal the cell's energy status.

There are several isoforms of PFK found in different tissues, including PFK-1 (or muscle PFK) and PFK-2 (or liver PFK), which exhibit tissue-specific patterns of expression and regulation. Mutations in the genes encoding PFK can result in various inherited metabolic disorders, such as Tarui's disease, characterized by exercise intolerance, muscle cramps, and myoglobinuria.

A muscle is a soft tissue in our body that contracts to produce force and motion. It is composed mainly of specialized cells called muscle fibers, which are bound together by connective tissue. There are three types of muscles: skeletal (voluntary), smooth (involuntary), and cardiac. Skeletal muscles attach to bones and help in movement, while smooth muscles are found within the walls of organs and blood vessels, helping with functions like digestion and circulation. Cardiac muscle is the specific type that makes up the heart, allowing it to pump blood throughout the body.

Adenosine Triphosphate (ATP) is a high-energy molecule that stores and transports energy within cells. It is the main source of energy for most cellular processes, including muscle contraction, nerve impulse transmission, and protein synthesis. ATP is composed of a base (adenine), a sugar (ribose), and three phosphate groups. The bonds between these phosphate groups contain a significant amount of energy, which can be released when the bond between the second and third phosphate group is broken, resulting in the formation of adenosine diphosphate (ADP) and inorganic phosphate. This process is known as hydrolysis and can be catalyzed by various enzymes to drive a wide range of cellular functions. ATP can also be regenerated from ADP through various metabolic pathways, such as oxidative phosphorylation or substrate-level phosphorylation, allowing for the continuous supply of energy to cells.

  • There are two different phosphofructokinase enzymes in humans: Phosphofructokinase deficiency (GSD type VII, Tarui's disease) Hellinga HW, Evans PR (1987). (wikipedia.org)
  • In 1965, Tarui presented the first description of phosphofructokinase (PFK) deficiency in 3 adult siblings (born to consanguineous parents) with exercise intolerance and easy fatigability. (medscape.com)
  • Phosphofructokinase Deficiency (PFKD) is an autosomal recessive disorder that affects Cocker Spaniels. (animalgenetics.com)
  • Missense mutation in PFKM associated with muscle- type phosphofructokinase deficiency in the Wachtelhund dog, Inal Gultekin G, Raj K, Lehman S, Hillström A, Giger U. Mol Cell Probes. (animalgenetics.com)
  • A deficiency of 1-phosphofructokinase can be inherited due to the genetic disorder glycogenosis type VII Tarui's disease. (alchetron.com)
  • Although at least 14 unique GSDs are discussed in the literature, the 4 that cause clinically significant muscle weakness are Pompe disease (GSD type II, acid maltase deficiency), Cori disease (GSD type III, debranching enzyme deficiency), McArdle disease (GSD type V, myophosphorylase deficiency), and Tarui disease (GSD type VII, phosphofructokinase deficiency). (medscape.com)
  • In the reaction catalyzed by human platelet phosphofructokinase, Mg2+ is required for optimal activity. (uu.nl)
  • Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Phosphofructokinase, Platelet (PFKP) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. (bioemm.com)
  • Mechanistically, Snail regulates glycolytic activity via repression of phosphofructokinase, platelet (PFKP), a major isoform of cancer-specific phosphofructokinase-1 (PFK-1), an enzyme involving the first rate-limiting step of glycolysis. (elsevierpure.com)
  • Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. (prospecbio.com)
  • Phosphofructokinase (PFK) is a kinase enzyme that phosphorylates fructose 6-phosphate in glycolysis. (wikipedia.org)
  • Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Phosphofructokinase, Muscle (PFKM) in Tissue homogenates and other biological fluids. (hudsen.org)
  • This gene provides instructions for making one piece (the PFKM subunit) of an enzyme called phosphofructokinase, which plays a role in the breakdown of glycogen . (medlineplus.gov)
  • The phosphofructokinase enzyme is made up of four subunits and is found in a variety of tissues. (medlineplus.gov)
  • the phosphofructokinase enzyme is composed solely of PFKM subunits. (medlineplus.gov)
  • In other tissues, other subunits that make up the phosphofructokinase enzyme likely compensate for the lack of PFKM subunits, and the enzyme is able to retain some function. (medlineplus.gov)
  • The phosphofructokinase-1 (PFK-1) enzyme is important for the catalyzation and regulation of glycolysis, especially in muscle. (usd.edu)
  • 1-phosphofructokinase catalyzes the committed step of glycolysis. (alchetron.com)
  • Therefore when glucagon inhibits phosphofructokinase 2, cellular levels of fructose 2,6-bisphosphate decrease, and reduce activation of 1-phosphofructokinase, ultimately reducing the rate of glycolysis within the cell. (alchetron.com)
  • As concentrations of fructose 2,6-bisphosphate increase, 1-phosphofructokinase is allosterically activated, and rates of glycolysis increase, consuming glucose. (alchetron.com)
  • Hexokinase (HK), phosphofructokinase-1 (PFK-1) and pyruvate kinase (PK) are the three key enzymes in the glycolysis pathway. (researchsquare.com)
  • The image is a painting titled Phosphofructokinase-1, the 'gatekeeper of glycolysis' . (portlandpress.com)
  • Description: A sandwich quantitative ELISA assay kit for detection of Human Phosphofructokinase, Muscle (PFKM) in samples from tissue homogenates or other biological fluids. (hudsen.org)
  • It has been reported that lung cancer cells exhibit upregulated expression of all key glycolytic enzymes [hexokinase 2 (HK2), phosphofructokinase and pyruvate kinase (PK)] ( 13 ), suggesting that the essential enzymes of the aerobic glycolytic pathway have a critical role in the development of lung carcinoma. (spandidos-publications.com)
  • Phosphofructokinase catalyses the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, a key regulatory step in the glycolytic pathway. (wikipedia.org)
  • Effect of fructose 2, 6‐bisphosphate on 6‐phosphofructokinase (ATP: D‐fructose‐6‐phosphate 1‐phosphotransferase, EC 2.7.1.11) in spermatid extract from rat testes was studied. (elsevierpure.com)
  • Description: A sandwich ELISA kit for detection of Phosphofructokinase, Muscle from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. (hudsen.org)
  • Structural and Regulatory Studies on Rabbit Muscle Phosphofructokinase. (lsu.edu)
  • Phosphofructokinase is involved in the sequence of events that breaks down glycogen to provide energy to muscle cells. (medlineplus.gov)
  • When blood glucose levels are low, the secretion of glucagon leads to the phosphorylation of phosphofructokinase 2 which inhibits formation of fructose 2,6-bisphosphate. (alchetron.com)
  • We describe the development of novel small molecule allosteric inhibitors of trypanosome phosphofructokinase (PFK) that block the glycolytic pathway resulting in very fast parasite kill times with no inhibition of human PFKs. (york.ac.uk)
  • The regulation of 1-phosphofructokinase occurs primarily by allosteric effectors, and is based on the cell's energy needs. (alchetron.com)
  • ATP acts as an allosteric inhibitor and when cellular concentrations of ATP are high, and the cell's energy needs are low, the reaction catalyzed by 1-phosphofructokinase is inhibited. (alchetron.com)
  • An increased concentration of citrate indicates the cell is meeting current energy needs, and therefore encourages allosteric inhibition of 1-phosphofructokinase allosterically via ATP. (alchetron.com)
  • Allosteric regulation of 1-phosphofructokinase is facilitated hormonally to help the liver to maintain blood glucose levels. (alchetron.com)
  • Other names in common use include fructose-1-phosphate kinase , 1-phosphofructokinase (phosphorylating) , D-fructose-1-phosphate kinase , fructose 1-phosphate kinase , and 1-phosphofructokinase . (alchetron.com)
  • When blood sugar is high, however, the secretion of insulin produces the opposite effect by removing the phosphate group from phosphofructokinase 2, which leads to activation, and formation of fructose 2,6-bisphosphate. (alchetron.com)
  • The distribution of phosphofructokinase (PFK) phosphoryl donor subtypes [ATP-, ADP- and pyrophosphate (PPᵢ)] in the deeply rooted phylogenetic lineages of thermophiles is of interest with respect to the evolution of PFK activity and of the Embden-Meyerhof (EM) pathway. (waikato.ac.nz)
  • citation needed] PFK belongs to the phosphofructokinase B (PfkB) family of sugar kinases. (wikipedia.org)
  • 1-Phosphofructokinase is a tetramer of 4 identical subunits that each have a catalytic site. (alchetron.com)
  • As a result, no functional phosphofructokinase is formed in skeletal muscles, and glycogen cannot be completely broken down. (medlineplus.gov)
  • AMP and ADP are both positive effectors of 1-phosphofructokinase and bind allosterically to activate the reaction. (alchetron.com)
  • Phosphofructokinase-1, Liver Type" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uams.edu)
  • This graph shows the total number of publications written about "Phosphofructokinase-1, Liver Type" by people in UAMS Profiles by year, and whether "Phosphofructokinase-1, Liver Type" was a major or minor topic of these publications. (uams.edu)
  • Below are the most recent publications written about "Phosphofructokinase-1, Liver Type" by people in Profiles over the past ten years. (uams.edu)
  • Phosphofructokinase activity remained unaltered during growth. (avma.org)
  • Fructose 2, 6‐bisphosphate (0.8 μM) was required for 50% activation of 6‐phosphofructokinase (PFK). (elsevierpure.com)
  • Other members of this family (also known as the Ribokinase family) include ribokinase (RK), adenosine kinase (AK), inosine kinase, and 1-phosphofructokinase. (wikipedia.org)
  • When 1-phosphofructokinase is inhibited, rates of gluconeogenesis increase, further aiding an increase in blood sugar. (alchetron.com)
  • 3. Metformin reverses hexokinase and phosphofructokinase downregulation and intracellular distribution in the heart of diabetic mice. (nih.gov)
  • The structure was solved by molecular replacement using the known structure of Bacillus stearothermophilus phosphofructokinase, and has been refined to a crystallographic R-factor of 0.165 for all data. (nih.gov)
  • In this study, we tested how phosphofructokinase-1 (PFK1) activity controls the fate of glucose-derived carbon in murine hearts in vivo. (nih.gov)
  • citation needed] PFK belongs to the phosphofructokinase B (PfkB) family of sugar kinases. (wikipedia.org)
  • However, AdK sequences exhibit low (~ 20-25%), but significant similarity to other PfkB family of proteins such as RK and phosphofructokinases, which are also found in prokaryotic organisms. (wikipedia.org)
  • 9. Characterization of expression of phosphofructokinase isoforms in isolated rat pancreatic islets and purified beta cells and cloning and expression of the rat phosphofructokinase-A isoform. (nih.gov)
  • The crystal structure of Escherichia coli phosphofructokinase complexed with its reaction products fructose 1,6-bisphosphate (Fru1,6P) and ADP/Mg2+, and the allosteric activator ADP/Mg2+, has been determined at 2.4 A resolution. (nih.gov)
  • The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle. (nih.gov)
  • In the isolated frog sartorius incubated at 20°C in 5 x 10 -7 M E a rise in phosphorylase a can be demonstrated in less than 5 min and this is followed after a lag period of a few minutes by a rise in glucose-6-P, but an increased lactate production through activation of phosphofructokinase does not take place until after 30 min of incubation. (aspetjournals.org)
  • This review provides an overview of the current knowledge of eukaryotic 6-phosphofructokinase based on recent crystal structures, kinetic analyses and site-directed mutagenesis data with special focus on the molecular architecture and the structural basis of allosteric regulation. (nih.gov)
  • Schoneberg T, Kloos M, Bruser A, Kirchberger J, Strater N. Structure and allosteric regulation of eukaryotic 6-phosphofructokinases. (medlineplus.gov)
  • Crystal structure of human platelet phosphofructokinase-1 locked in an activated conformation. (nih.gov)
  • Other members of this family (also known as the Ribokinase family) include ribokinase (RK), adenosine kinase (AK), inosine kinase, and 1-phosphofructokinase. (wikipedia.org)
  • In vivo deep network tracing reveals phosphofructokinase-mediated coordination of biosynthetic pathway activity in the myocardium. (nih.gov)

No images available that match "phosphofructokinases"